ECOR electroCore, Inc. - Common Stock
$10,66
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$4–$11
100% of range
Analystenbewertung
BUY
11 analysts
Kursziel
$20
+84% upside
P/E (TTM)
-6.5
ROE
4686.6%
Nettogewinnmarge
-43.6%
ECOR Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$10.66
Marktkapitalisierung
$85M
P/E (TTM)
-6.5
EPS (TTM)
$-1.65
Umsatz (TTM)
$32M
Dividendenrendite
—
ROE
4686.6%
Verschuldungsgrad
-3.9
52W-Spanne
$4 – $11
ECOR Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$32M
2017-12-31
→
2025-12-31
EPS
$-1.65
2021-12-31
→
2025-12-31
Freier Cashflow
$-8M
2018-12-31
→
2025-12-31
Margen
-43.6%
2018-12-31
→
2025-12-31
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ECOR
Peer-Median
P/E (TTM)
-6.5
15.0
P/S (TTM) (K/V (TTM))
2.7
3.0
P/B (K/B)
-49.9
2.9
EV / EBITDA
-6.1
—
Price / FCF (Kurs / FCF)
-10.3
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ECOR
Peer-Median
Gross Margin (Bruttogewinnmarge)
86.8%
66.0%
Operating Margin (Betriebsgewinnmarge)
-41.1%
—
Net Profit Margin (Nettogewinnmarge)
-43.6%
-61.9%
ROA
-71.4%
-33.8%
ROE
4686.6%
-74.4%
ROIC
-268.6%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ECOR
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
-3.9
—
Current Ratio (Liquiditätsgrad)
1.4
3.6
Quick Ratio
1.1
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ECOR
Peer-Median
Revenue YoY (Umsatz YoY)
27.2%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
55.1%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
55.7%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ECOR
Peer-Median
ECOR Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
11 Analysten
- Starker Kauf 3 27,3%
- Kauf 7 63,6%
- Halten 1 9,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
5 Analysten · 2026-08-17
Median
$19.85
← Unter allen Zielen
$10.66
Tief
$12.00
Hoch
$26.00
Median-Ziel
$19.85
+86,2%
Mittelwert-Ziel
$19.57
+83,6%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.03%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.33 | $-0.43 | 0.10% |
| 31. März 2026 | $-0.37 | $-0.62 | 0.25% |
| 31. Dezember 2025 | $-0.34 | $-0.42 | 0.08% |
| 30. September 2025 | $-0.40 | $-0.40 | 0.00% |
| 30. Juni 2025 | $-0.44 | $-0.31 | -0.13% |
| 31. März 2025 | $-0.47 | $-0.48 | 0.01% |
| 31. Dezember 2024 | $-0.40 | $-0.31 | -0.09% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ECOR | $36M | -2.7 | 27.2% | -43.6% | 4686.6% | 86.8% |
| MBOT | $134M | -6.9 | — | — | -24.4% | — |
| KEQU | $106M | 11.5 | 17.3% | 3.4% | 13.3% | 28.5% |
| LNSR | — | -4.1 | 9.2% | — | — | — |
| HSDT | $126M | -1.6 | 1057.1% | -679.6% | -26.6% | 91.7% |
| HYPR | — | -2.3 | 5.2% | -262.3% | -93.5% | 49.8% |
| LUNG | $92M | -1.7 | 8.0% | -59.7% | -87.7% | 74.2% |
| STEX | $151M | -0.3 | 122.2% | 29068.8% | -703.0% | — |
| OM | $67M | -0.7 | 5.1% | -68.3% | -58.0% | 39.1% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $32M | $25M | $16M | $9M | $5M | $3M | $2M | $993.0K | $811.5K | |
| Cost of Revenue | $4M | $4M | $3M | $2M | $1M | $2M | $1M | $578.7K | $518.5K | |
| Gross Profit | $28M | $21M | $13M | $7M | $4M | $2M | $1M | $414.2K | $292.9K | |
| R&D Expense | · | $2M | $5M | $6M | $3M | $4M | $10M | $12M | $8M | |
| SG&A Expense | $38M | $31M | $27M | $24M | $22M | $22M | $35M | $43M | $18M | |
| Operating Expenses | $41M | $34M | $32M | $30M | $24M | $27M | $47M | $55M | $26M | |
| Operating Income | $-13M | $-12M | $-19M | $-23M | $-20M | $-25M | $-46M | $-55M | $-26M | |
| Interest Expense | $14.9K | $18.4K | · | $4.0K | · | · | · | · | $6M | |
| Other Non-op | $-810.0K | $183.0K | $249.0K | $281.0K | $2M | $66.6K | $958.3K | $-1M | $-10M | |
| Pretax Income | $-14M | $-12M | $-19M | $-23M | $-18M | $-25M | $-45M | $-56M | $-36M | |
| Income Tax | $3.0K | $-93.0K | $-186.0K | $-431.0K | $-851.0K | $-1M | $17.7K | $2.4K | · | |
| Net Income | $-14M | $-12M | $-19M | $-22M | $-17M | $-24M | $-45M | $-56M | $-36M | |
| EPS (Basic) | $-1.65 | $-1.59 | $-3.42 | $-4.69 | $-4.36 | · | · | · | · | |
| EPS (Diluted) | $-1.65 | $-1.59 | $-3.42 | $-4.69 | $-4.36 | · | · | · | · | |
| Shares (Basic) | 8,483 | 7,483 | 5,515,000 | 4,729 | 3,945 | · | · | · | · | |
| Shares (Diluted) | 8,483 | 7,483 | 5,515,000 | 4,729 | 3,945 | · | · | · | · | |
| EBITDA | $-13M | $-11M | $-18M | · | · | $-24M | $-46M | $-54M | · |
Bilanz 26
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $4M | $10M | $18M | $35M | $4M | $14M | $8M | $13M | |
| Short-term Investments | $5M | $9M | · | · | · | · | · | · | $24M | |
| Receivables | $1M | $1M | $717.0K | $401.0K | $438.0K | $270.5K | $496.1K | $267.6K | $103.2K | |
| Inventory | $2M | $2M | $2M | $2M | $1M | $876.4K | $891.0K | $2M | $327.8K | |
| Prepaid Expense | $1M | $1M | $836.0K | $828.0K | $1M | $1M | $1M | $2M | $570.8K | |
| Current Assets | $16M | $16M | $14M | $21M | $38M | $25M | $27M | $73M | $39M | |
| PP&E (Net) | $382.0K | $158.0K | $204.0K | $50.0K | $147.0K | $244.0K | $345.2K | $380.9K | $168.6K | |
| PP&E (Gross) | · | · | · | · | · | · | $733.6K | $731.2K | $747.7K | |
| Accum. Depreciation | · | · | · | · | · | · | $388.4K | $350.3K | $579.0K | |
| Other Non-current Assets | $54.0K | $274.0K | $495.0K | $774.0K | $591.0K | $828.0K | $1M | $424.9K | $30.6K | |
| Total Assets | $19M | $20M | $16M | $25M | $43M | $32M | $35M | $74M | $39M | |
| Accounts Payable | $3M | $2M | $2M | $2M | $938.0K | $2M | $5M | $3M | $840.4K | |
| Accrued Liabilities | $8M | $7M | $6M | $5M | $4M | $3M | $3M | $4M | · | |
| Short-term Debt | · | · | $247.0K | $264.0K | · | · | · | · | · | |
| Current Liabilities | $11M | $9M | $8M | $7M | $5M | $6M | $9M | $7M | $6M | |
| Capital Leases | $2M | $4M | $537.0K | $625.0K | $700.0K | $885.3K | $1M | · | · | |
| Total Liabilities | $20M | $13M | $9M | $8M | $6M | $8M | $11M | $7M | $6M | |
| Long-term Debt | $8M | · | · | · | · | · | · | · | · | |
| Total Debt | $7M | · | $247.0K | · | · | · | · | · | · | |
| Common Stock | $8.0K | $7.0K | $6.0K | $5.0K | $5.0K | $45.6K | $29.8K | · | · | |
| Paid-in Capital | · | · | · | · | · | $130M | $108M | · | · | |
| Retained Earnings | $-191M | $-177M | $-165M | $-146M | $-124M | $-107M | $-83M | $-38M | $-153M | |
| AOCI | $99.0K | $114.0K | $-64.0K | $-69.0K | $13.0K | $-251.5K | $-41.3K | $60.8K | $80.2K | |
| Stockholders' Equity | $-2M | $8M | $7M | $17M | $37M | $23M | $24M | $66M | $-90M | |
| Liabilities + Equity | $19M | $20M | $16M | $25M | $43M | $32M | $35M | $74M | $39M | |
| Shares Outstanding | 8,004,416 | 6,650,854 | 6,002,628 | 4,744,886 | 4,713,608 | 45,559,765 | 29,835,183 | 29,450,035 | 0 |
Cashflow 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $501.0K | $760.0K | $962.0K | $548.0K | $382.0K | $399.2K | $249.6K | $66.7K | $32.3K | |
| Stock-based Comp | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $8M | $462.3K | |
| Restructuring | · | · | · | · | · | $464.6K | · | · | · | |
| Other Non-cash | · | $2M | $2M | · | · | $-257.1K | $-4M | $1M | · | |
| Operating Cash Flow | $-8M | $-7M | $-15M | $-17M | $-14M | $-20M | $-45M | $-47M | $-25M | |
| CapEx | $66.0K | · | $206.0K | · | · | · | $69.7K | $278.9K | $152.5K | |
| Investing Cash Flow | $4M | $-9M | $-206.0K | · | $18M | $-8M | $51M | $-37M | $-24M | |
| Debt Issued | $8M | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $8M | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | $8M | · | · | · | · | $78M | · | |
| Net Stock Activity | · | · | $8M | · | · | · | · | $78M | · | |
| Financing Cash Flow | $8M | $8M | $7M | · | $26M | $19M | $160.8K | $78M | $62M | |
| Net Change in Cash | · | $-7M | $-7M | $-17M | $30M | $-9M | $6M | $-6M | $13M | |
| Taxes Paid | $11.0K | $6.0K | · | · | $39.0K | $3.8K | $29.5K | $45.6K | · | |
| Free Cash Flow | $-8M | · | $-15M | · | · | · | $-45M | $-47M | · | |
| Levered FCF | $-8M | · | · | · | · | · | · | · | · |
Rentabilität 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.8% | 85.0% | 82.5% | · | · | 50.3% | 51.6% | 41.7% | · | |
| Operating Margin | -41.1% | -48.3% | -120.2% | · | · | -707.9% | -1928.2% | -5494.1% | · | |
| Net Margin | -43.6% | -47.2% | -117.5% | · | · | -672.6% | -1888.8% | -5621.7% | · | |
| Pretax Margin | -43.6% | -47.6% | -118.7% | · | · | -706.0% | -1888.1% | -5615.9% | · | |
| EBITDA Margin | -41.1% | -45.3% | -114.2% | · | · | -696.5% | -1917.7% | -5487.4% | · | |
| ROA | -71.4% | -65.0% | -92.2% | · | · | -70.2% | -82.9% | -99.0% | · | |
| ROE | 4686.6% | -139.8% | -203.8% | · | · | -99.5% | -100.5% | 455.3% | · | |
| ROIC | -268.6% | -160.0% | -248.2% | · | · | -102.5% | -190.0% | -83.2% | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.8 | 1.8 | · | · | 4.3 | 2.9 | 10.3 | · | |
| Quick Ratio | 1.1 | 1.5 | 1.4 | · | · | 0.8 | 1.5 | 1.1 | · | |
| Debt / Equity | -3.9 | · | 0.0 | · | · | · | · | · | · | |
| LT Debt / Equity | -3.9 | · | · | · | · | · | · | · | · | |
| Interest Coverage | -882.8 | · | · | · | · | · | · | · | · |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.6 | 1.4 | 0.8 | · | · | 0.1 | 0.0 | 0.0 | · | |
| Inventory Turnover | 2.6 | 2.0 | 1.4 | · | · | 2.0 | 0.8 | 0.5 | · | |
| Receivables Turnover | 26.8 | 24.2 | 28.7 | · | · | 9.1 | 6.3 | 5.4 | · |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 27.2% | 57.1% | 86.6% | 57.6% | 55.9% | · | · | · | · | |
| Revenue CAGR 3Y | 55.1% | 66.5% | 66.1% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 55.7% | · | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $32M | $25M | $16M | $9M | $5M | $3M | $2M | $993.0K | · | |
| Net Income TTM | $-14M | $-12M | $-19M | $-22M | $-17M | $-24M | $-45M | $-56M | · | |
| Market Cap | $36M | $108M | $36M | · | · | $1.07B | $712M | $2.77B | · | |
| Enterprise Value | $31M | · | $26M | · | · | · | · | · | · | |
| P/E | -2.7 | -10.2 | -1.7 | -0.8 | -2.0 | · | · | · | · | |
| P/S | 1.1 | 4.3 | 2.2 | · | · | 305.0 | 297.7 | 2785.0 | · | |
| P/B | -21.0 | 14.3 | 4.8 | · | · | 46.3 | 29.3 | 42.2 | · | |
| P / Tangible Book | · | 14.3 | 4.8 | 1.1 | 16.9 | 46.3 | · | · | · | |
| P / Cash Flow | -4.4 | -15.5 | -2.4 | · | · | -53.0 | -15.8 | -58.7 | · | |
| P / FCF | -4.3 | · | -2.4 | · | · | · | -15.8 | -58.4 | · | |
| EV / EBITDA | -2.3 | · | -1.4 | · | · | · | · | · | · | |
| EV / FCF | -3.7 | · | -1.7 | · | · | · | · | · | · | |
| EV / Revenue | 1.0 | · | 1.6 | · | · | · | · | · | · | |
| Earnings Yield | -36.8% | -9.8% | -57.5% | -121.7% | -49.9% | · | · | · | · |
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9M | $10M | $9M | $9M | $7M | $7M | $7M | $7M | $6M | $5M | $5M | $5M | $4M | $3M | $3M | $2M | |
| Cost of Revenue | $1M | $1M | $1M | $1M | $939.0K | $1M | $994.0K | $1M | $838.0K | $888.0K | $1M | $661.0K | $585.0K | $458.0K | $640.0K | $258.0K | |
| Gross Profit | $8M | $8M | $8M | $7M | $6M | $6M | $6M | $5M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $2M | |
| R&D Expense | · | · | · | $662.0K | $511.0K | $642.0K | · | $521.0K | $635.0K | $399.0K | $1M | $1M | $1M | $2M | $2M | $2M | |
| SG&A Expense | $10M | $13M | $10M | $10M | $9M | $9M | $8M | $8M | $7M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | |
| Operating Expenses | $11M | $14M | $11M | $10M | $10M | $10M | $9M | $8M | $8M | $8M | $8M | $8M | $8M | $9M | $8M | $7M | |
| Operating Income | $-3M | $-5M | $-3M | $-3M | $-4M | $-4M | $-3M | $-3M | $-3M | $-4M | $-4M | $-4M | $-5M | $-6M | $-6M | $-6M | |
| Interest Expense | $3.3K | $4.0K | $2.1K | $3.3K | $4.5K | $5.0K | $4.9K | $5.0K | $4.3K | $4.2K | · | · | $2.2K | $2.0K | · | · | |
| Other Non-op | $-287.0K | $-276.0K | $-43.0K | $-521.0K | $-165.0K | $-81.0K | $-128.0K | $154.0K | $-64.0K | $221.0K | $-49.0K | $94.0K | $85.0K | $119.0K | $141.0K | $103.0K | |
| Pretax Income | $-3M | $-6M | $-3M | $-3M | $-4M | $-4M | $-3M | $-2M | $-3M | $-4M | $-4M | $-4M | $-5M | $-6M | $-6M | $-5M | |
| Income Tax | · | $-321.0K | $51.0K | · | · | $-48.0K | $29.0K | · | · | $-122.0K | $25.0K | · | · | $-211.0K | $14.0K | · | |
| Net Income | $-3M | $-5M | $-3M | $-3M | $-4M | $-4M | $-3M | $-2M | $-3M | $-4M | $-4M | $-4M | $-5M | $-6M | $-6M | $-5M | |
| EPS (Basic) | $-0.33 | $-0.59 | $-0.34 | $-0.40 | $-0.44 | $-0.47 | $-0.37 | $-0.31 | $-0.38 | $-0.53 | $-0.47 | $-0.68 | $-1.03 | $-1.24 | $-1.09 | $-1.20 | |
| EPS (Diluted) | $-0.33 | $-0.59 | $-0.34 | $-0.40 | $-0.44 | $-0.47 | $-0.37 | $-0.31 | $-0.38 | $-0.53 | $-0.47 | $-0.68 | $-1.03 | $-1.24 | $-1.09 | $-1.20 | |
| Shares (Basic) | 9,404 | 8,953 | -16,567 | 8,445 | 8,316 | 8,289 | -14,273 | 8,093 | 7,046 | 6,617 | -9,924,000 | 5,945,000 | 4,751,000 | 4,743,000 | -13,639,271 | 4,544,000 | |
| Shares (Diluted) | 9,404 | 8,953 | -16,567 | 8,445 | 8,316 | 8,289 | -14,273 | 8,093 | 7,046 | 6,617 | -9,924,000 | 5,945,000 | 4,751,000 | 4,743,000 | -13,639,271 | 4,544,000 | |
| EBITDA | $-3M | $-5M | · | $-3M | $-4M | $-4M | · | $-3M | $-3M | $-4M | · | $-4M | $-5M | $-6M | · | $-6M |
Bilanz 23
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $5M | $7M | $8M | $3M | $4M | $4M | $5M | $10M | $8M | $10M | $13M | $8M | $12M | $18M | $22M | |
| Short-term Investments | $2M | $4M | $5M | $5M | $4M | $4M | $9M | $8M | $4M | · | · | · | · | · | · | · | |
| Receivables | $909.0K | $872.0K | $1M | $1M | $813.0K | $1M | $1M | $552.0K | $538.0K | $475.0K | $717.0K | $589.0K | $238.0K | $213.0K | $401.0K | $364.0K | |
| Inventory | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Prepaid Expense | $752.0K | $846.0K | $1M | $1M | $922.0K | $771.0K | $1M | $1M | $360.0K | $629.0K | $836.0K | $1M | $106.0K | $525.0K | $828.0K | $1M | |
| Current Assets | $14M | $13M | $16M | $17M | $11M | $12M | $16M | $17M | $18M | $12M | $14M | $18M | $11M | $15M | $21M | $25M | |
| PP&E (Net) | $375.0K | $364.0K | $382.0K | $194.0K | $197.0K | $183.0K | $158.0K | $170.0K | $181.0K | $192.0K | $204.0K | $178.0K | $114.0K | $34.0K | $50.0K | $77.0K | |
| Other Non-current Assets | $54.0K | $54.0K | $54.0K | $243.0K | $142.0K | $186.0K | $274.0K | $364.0K | $440.0K | $448.0K | $495.0K | $760.0K | $819.0K | $891.0K | $774.0K | $853.0K | |
| Total Assets | $17M | $15M | $19M | $21M | $15M | $16M | $20M | $21M | $22M | $14M | $16M | $20M | $14M | $18M | $25M | $29M | |
| Accounts Payable | $2M | $2M | $3M | $3M | $3M | $2M | $2M | $1M | $1M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | |
| Accrued Liabilities | $8M | $10M | $8M | $9M | $7M | $6M | $7M | $6M | $5M | $5M | $6M | $5M | $4M | $4M | $5M | $5M | |
| Short-term Debt | $1M | $250.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | $521.7K | |
| Current Liabilities | $12M | $12M | $11M | $12M | $10M | $8M | $9M | $8M | $7M | $8M | $8M | $9M | $7M | $6M | $7M | $7M | |
| Capital Leases | $2M | $2M | $2M | $4M | $4M | $4M | $4M | $4M | $4M | $2M | $537.0K | $560.0K | $583.0K | $605.0K | $625.0K | $645.0K | |
| Total Liabilities | $20M | $21M | $20M | $22M | $13M | $12M | $13M | $12M | $11M | $9M | $9M | $9M | $7M | $6M | $8M | $7M | |
| Long-term Debt | $8M | $8M | $8M | $8M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $7M | $7M | · | $7M | · | · | · | · | · | · | · | · | · | · | · | $521.7K | |
| Common Stock | $9.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | · | · | · | $6.0K | · | · | · | $5.0K | · | |
| Retained Earnings | $-199M | $-196M | $-191M | $-188M | $-185M | $-181M | $-177M | $-174M | $-171M | $-169M | $-165M | $-161M | $-157M | $-152M | $-146M | $-141M | |
| AOCI | $22.0K | $-64.0K | $99.0K | $-15.0K | $-19.0K | $70.0K | $114.0K | $177.0K | $45.0K | $12.0K | $-64.0K | $-98.0K | $-76.0K | $-13.0K | $-69.0K | $-154.0K | |
| Stockholders' Equity | $-3M | $-6M | $-2M | $-1M | $1M | $4M | $8M | $9M | $11M | $4M | $7M | $11M | $7M | $12M | $17M | $22M | |
| Liabilities + Equity | $17M | $15M | $19M | $21M | $15M | $16M | $20M | $21M | $22M | $14M | $16M | $20M | $14M | $18M | $25M | $29M | |
| Shares Outstanding | 9,001,540 | 8,125,613 | 8,004,416 | 7,635,166 | 7,466,425 | 7,420,452 | 6,650,854 | 6,507,011 | 6,446,866 | 6,006,064 | 6,002,628 | 5,998,836 | 4,752,475 | 4,745,781 | 4,744,886 | 71,121,565 |
Cashflow 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6.0K | $21.0K | $107.0K | $118.0K | $121.0K | $155.0K | $168.0K | $185.0K | $201.0K | $206.0K | $227.0K | $291.0K | $322.0K | $122.0K | $148.0K | $153.0K | |
| Stock-based Comp | $755.0K | $1M | $470.0K | $415.0K | $505.0K | $540.0K | $514.0K | $400.0K | $472.0K | $484.0K | $400.0K | $543.0K | $183.0K | $572.0K | $587.0K | $566.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $258.0K | · | · | · | $-687.0K | · | · | |
| Operating Cash Flow | $-4M | $-3M | $-2M | $-2M | $-623.0K | $-4M | $-1M | $-1M | $-2M | $-3M | $-3M | $-2M | $-3M | $-6M | $-4M | $-5M | |
| CapEx | $4.0K | $2.0K | $0 | $4.0K | $25.0K | $37.0K | · | · | · | · | $41.0K | $74.0K | · | · | · | · | |
| Investing Cash Flow | $2M | $597.0K | $518.0K | $-1M | $185.0K | $4M | $-501.0K | $-4M | · | · | $-41.0K | $-74.0K | · | · | · | · | |
| Debt Issued | · | · | $0 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $5M | $230.0K | $-40.0K | $7M | $3.0K | $180.0K | $371.0K | $-52.0K | · | · | $0 | · | · | · | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | $-5M | $2M | $-2M | $-3M | $5M | $-3M | $-6M | $-4M | $-5M | |
| Free Cash Flow | · | $-3M | · | · | · | $-4M | · | · | · | · | · | · | · | · | · | · | |
| Levered FCF | · | $-3M | · | · | · | $-4M | · | · | · | · | · | · | · | · | · | · |
Rentabilität 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 86.5% | 87.3% | · | 86.0% | 87.3% | 84.9% | · | 83.8% | 86.4% | 83.7% | · | 85.3% | 83.5% | 83.5% | · | 86.9% | |
| Operating Margin | -29.3% | -55.5% | · | -33.2% | -47.5% | -56.9% | · | -40.5% | -42.2% | -70.7% | · | -91.5% | -140.5% | -222.9% | · | -281.2% | |
| Net Margin | -32.4% | -55.0% | · | -39.2% | -49.7% | -57.4% | · | -38.1% | -43.2% | -64.4% | · | -89.4% | -138.1% | -211.0% | · | · | |
| Pretax Margin | -32.4% | -58.4% | · | -39.2% | -49.7% | -58.1% | · | -38.1% | -43.2% | -66.6% | · | -89.4% | -138.1% | -218.6% | · | -276.0% | |
| EBITDA Margin | -29.3% | -55.5% | · | -33.2% | -47.5% | -56.9% | · | -40.5% | -42.2% | -66.9% | · | -91.5% | -140.5% | -218.5% | · | -281.2% | |
| ROA | -19.4% | -33.4% | · | -16.0% | -19.9% | -25.8% | · | -12.1% | -14.5% | -21.8% | · | -16.3% | -20.6% | -21.1% | · | · | |
| ROE | 364.8% | 796.8% | · | -81.2% | -58.3% | -87.0% | · | -24.4% | -28.6% | -42.9% | · | -24.3% | -28.6% | -26.9% | · | · | |
| ROIC | · | -501.6% | · | · | · | -86.5% | · | · | · | -82.7% | · | · | · | -50.5% | · | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.0 | · | 1.4 | 1.1 | 1.5 | · | 2.1 | 2.5 | 1.5 | · | 2.1 | 1.7 | 2.6 | · | 3.8 | |
| Quick Ratio | 0.9 | 0.8 | · | 1.2 | 0.8 | 1.2 | · | 1.7 | 2.0 | 1.1 | · | 1.7 | 1.3 | 2.1 | · | 3.3 | |
| Debt / Equity | -2.4 | -1.2 | · | -6.1 | · | · | · | · | · | · | · | · | · | · | · | 0.0 | |
| LT Debt / Equity | -2.1 | -1.1 | · | -6.1 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | -840.0 | -1329.0 | · | -873.9 | -779.1 | -764.4 | · | · | · | · | · | · | -2216.9 | -3045.2 | · | · |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.8 | 0.5 | 0.5 | · | 0.5 | 0.3 | 0.4 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | |
| Receivables Turnover | 11.0 | 8.2 | · | 8.6 | 10.9 | 6.9 | · | 11.5 | 15.8 | 15.8 | · | 9.5 | 8.7 | 9.6 | · | 5.7 |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $35M | $32M | · | $29M | $27M | $25M | · | $23M | $20M | $16M | · | $13M | $10M | $9M | · | $8M | |
| Net Income TTM | $-15M | $-16M | · | $-13M | $-13M | $-13M | · | $-13M | $-15M | $-18M | · | $-20M | $-22M | $-22M | · | $-20M | |
| Market Cap | $78M | $49M | · | $38M | $39M | $50M | · | $47M | $41M | $37M | · | $36M | $23M | $26M | · | $433M | |
| Enterprise Value | $74M | $47M | · | $31M | · | · | · | · | · | · | · | · | · | · | · | $412M | |
| P/E | -4.9 | -3.2 | · | -3.1 | -3.3 | -4.0 | · | -3.8 | -2.5 | -1.8 | · | -1.5 | -1.0 | -1.1 | · | · | |
| P/S | 2.2 | 1.5 | · | 1.3 | 1.5 | 2.0 | · | 2.1 | 2.1 | 2.3 | · | 2.8 | 2.2 | 3.0 | · | 57.6 | |
| P/B | -27.9 | -8.6 | · | -35.2 | 35.4 | 11.4 | · | 5.0 | 3.6 | 8.2 | · | 3.3 | 3.3 | 2.2 | · | 19.5 | |
| P / Tangible Book | · | · | · | · | 35.4 | 11.4 | · | 5.0 | 3.6 | 8.2 | · | 3.3 | 3.3 | 2.2 | · | 19.5 | |
| P / Cash Flow | · | -16.3 | · | · | · | -11.4 | · | · | · | -14.5 | · | · | · | -4.5 | · | · | |
| P / FCF | · | -16.3 | · | · | · | -11.3 | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | -26.9 | -8.8 | · | -10.9 | · | · | · | · | · | · | · | · | · | · | · | -74.2 | |
| EV / FCF | · | -15.6 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 2.1 | 1.4 | · | 1.1 | · | · | · | · | · | · | · | · | · | · | · | 54.8 | |
| Earnings Yield | -20.4% | -31.5% | · | -32.7% | -30.3% | -25.3% | · | -26.3% | -40.8% | -56.4% | · | -68.4% | -95.3% | -88.0% | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $32M | $25M | $16M | $9M | $5M |
| Bruttogewinnmarge % | 86.8% | 85.0% | 82.5% | — | — |
| Betriebsgewinnmarge % | -41.1% | -48.3% | -120.2% | — | — |
| Nettoergebnis | $-14M | $-12M | $-19M | $-22M | $-17M |
| Verwässerte EPS | $-1.65 | $-1.59 | $-3.42 | $-4.69 | $-4.36 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | -3.9 | — | 0.0 | — | — |
| Liquiditätsgrad | 1.4 | 1.8 | 1.8 | — | — |
| Quick Ratio | 1.1 | 1.5 | 1.4 | — | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-8M | — | $-15M | — | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 35 Einreicher · $8.4M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 11 (+7 vs. Vorquartal) | 5 (0 vs. Vorquartal) | 4 (0 vs. Vorquartal) | 4 (-2 vs. Vorquartal) | +299K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.828.561 | 211.639 | 21,86% | Aktien |
| VANGUARD GROUP INC | $908.858 | 202.644 | 10,87% | Aktien |
| FourWorld Capital Management LLC | $812.160 | 94.000 | 9,71% | Aktien |
| WEXFORD CAPITAL LP | $795.398 | 92.060 | 9,51% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $518.919 | 60.043 | 6,20% | Aktien |
| Wealthspire Advisors, LLC | $410.383 | 47.498 | 4,91% | Aktien |
| JANE STREET GROUP, LLC | $385.776 | 44.650 | 4,61% | Aktien |
| Jaffetilchin Investment Partners, LLC | $350.934 | 58.198 | 4,20% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $334.973 | 38.770 | 4,00% | Aktien |
| HighTower Advisors, LLC | $305.355 | 35.342 | 3,65% | Aktien |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | $301.041 | 36.270 | 3,60% | Aktien |
| STATE STREET CORP | $229.116 | 26.518 | 2,74% | Aktien |
| WealthShield Partners, LLC | $224.450 | 25.978 | 2,68% | Aktien |
| BRC Group Holdings, Inc. | $216.899 | 25.104 | 2,59% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $216.000 | 25.000 | 2,58% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $171.936 | 19.900 | 2,06% | Aktien |
| NORTHERN TRUST CORP | $130.179 | 15.067 | 1,56% | Aktien |
| TOBIAS FINANCIAL ADVISORS, INC. | $86.400 | 10.000 | 1,03% | Aktien |
| BFSG, LLC | $33.368 | 3.862 | 0,40% | Aktien |
| MARSHALL WACE, LLP | $25.237 | 2.921 | 0,30% | Aktien |
| Rockefeller Capital Management L.P. | $16.813 | 1.946 | 0,20% | Aktien |
| Vanguard Global Advisers, LLC | $15.301 | 1.771 | 0,18% | Aktien |
| CITADEL ADVISORS LLC | $11.076 | 1.282 | 0,13% | Aktien |
| BlackRock, Inc. | $10.368 | 1.200 | 0,12% | Aktien |
| Kozak & Associates, Inc. | $5.528 | 666 | 0,07% | Aktien |
| Rialto Wealth Management, LLC | $5.478 | 634 | 0,07% | Aktien |
| WELLS FARGO & COMPANY/MN | $5.167 | 598 | 0,06% | Aktien |
| UBS Group AG | $4.882 | 565 | 0,06% | Aktien |
| Prestige Wealth Management Group LLC | $2.333 | 270 | 0,03% | Aktien |
| Allworth Financial LP | $623 | 72 | 0,01% | Aktien |
| BARCLAYS PLC | $605 | 70 | 0,01% | Aktien |
| JPMORGAN CHASE & CO | $406 | 50 | 0,00% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $207 | 24 | 0,00% | Aktien |
| TUCKER ASSET MANAGEMENT LLC | $58 | 13 | 0,00% | Aktien |
| MORGAN STANLEY | $9 | 1 | 0,00% | Aktien |
Unternehmensinsider 23 Insider · 5 Führungskräfte · 15 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Francis R. Amato | Chief Executive Officer | 7. Juni 2019 A | 358.831 | 0 | 0 | $0 |
| Joshua S. Lev | CFO and Interim President | 28. Mai 2026 S | 84.889 | 0 | 1 | $-60.003 |
| Brian M Posner | Chief Financial Officer | 12. Januar 2024 P | 22.437 | 0 | 0 | $0 |
| Glenn S. Vraniak | Chief Financial Officer | 22. März 2019 A | 120.811 | 0 | 0 | $0 |
| Peter S. Staats | Chief Medical Officer | 28. März 2019 A | 163.612 | 0 | 0 | $0 |
| James Charles Theofilos | Direktor | 1. August 2025 A | 23.547 | 0 | 0 | $0 |
| Theofilos Charles Steve | Direktor | 3. September 2024 A | 454.202 | 0 | 0 | $0 |
| Julie Ann Goldstein | Direktor | 3. September 2024 A | 77.380 | 0 | 0 | $0 |
| Patricia Wilber | Direktor | 3. September 2024 A | 49.697 | 0 | 0 | $0 |
| Thomas M Patton | Direktor | 3. September 2024 A | 83.771 | 0 | 0 | $0 |
| Peter F Cuneo | Direktor | 3. September 2024 A | 5.665 | 0 | 0 | $0 |
| John P Gandolfo | Direktor | 3. September 2024 A | 67.287 | 0 | 0 | $0 |
| Trevor J Moody | Direktor | 2. August 2023 P | 67.592 | 0 | 0 | $0 |
| Joseph P Errico | Direktor | 13. Dezember 2022 P | 2.724.841 | 0 | 0 | $0 |
| James L L Tullis | Direktor | 14. April 2020 P | 1.764.705 | 0 | 0 | $0 |
| Stephen Ondra | Direktor | 7. Juni 2019 A | — | 0 | 0 | $0 |
| Nicholas Colucci | Direktor | 7. Juni 2019 A | — | 0 | 0 | $0 |
| COX CARRIE SMITH | Direktor | 7. Juni 2019 A | 21.000 | 0 | 0 | $0 |
| Michael G Atieh | Direktor | 7. Juni 2019 A | — | 0 | 0 | $0 |
| Core Ventures II, LLC | 10%-Eigentümer | 19. November 2019 J | 646.342 | 0 | 0 | $0 |
| Merck Global Health Innovation Fund, LLC | 10%-Eigentümer | 21. Juni 2018 P | 3.346.032 | 0 | 0 | $0 |
| Thomas J. Errico | — | 13. August 2026 P | 343.332 | 1 | 0 | $49.250 |
| Daniel S Goldberger | — | 23. April 2026 S | 211.471 | 0 | 1 | $-544.000 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| MAZ Partners LP, MAZ Capital Advisors, LLC, Walter Schenker, Susan Schenker | 14. Mai 2025 | 1,80% | Erste Einreichung | Passive Anlage | SEC |
| Theofilos Charles Steve, Kathryn Theofilos, Happy Holstein Management, LLC, James Theofilos | 14. Mai 2025 | 6,00% | Änderung | Passive Anlage | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 7. Juni 2024 | — | Erste Einreichung | — | SEC |
| Charles Steve Theofilos, M.D. (2), Kathryn Theofilos (2), Happy Holstein Management, LLC (2) | 18. Dezember 2023 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 3 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.